Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only
Completed
Conditions studied: Asthma, Gastroesophageal Reflux Disease
In brief
There have been a number of studies which attribute causality between reflux disease and asthma. In addition, clinicians typically treat chronic asthmatics with high dose acid suppressing medications (e.g. lansoprazole). However, clinical trials only recently have shed some light on this dilemma, with recent studies suggesting that the association is not as clear. This "retrospective" analysis of a prospective study which treated mod-severe asthmatics with lansoprazole or placebo will enter the collected raw data into a database, then perform statistical analyses to determine if children with asthma treated with acid suppression improved their asthma compared to those receiving placebo.
Key facts
- Study ID
- NCT01536457
- Run by
- Children's Center for Digestive Health Care
- People needed
- 59
- Starts
- 2011-07-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2015-02-11
Who can join
Age: 4 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who were enrolled in the study, "Randomized, Double-blind, Placebo Controlled Study of Gastroesophageal Reflux Disease Therapy (Lansoprazole; Solutab™) in the Management of Childhood Asthma" will be entered into this database. Only these patients will be included in this study, all other patients will be excluded.
You may not qualify if…
- Patients who were not enrolled in the study, "Randomized, Double-blind, Placebo Controlled Study of Gastroesophageal Reflux Disease Therapy (Lansoprazole; Solutab™) in the Management of Childhood Asthma" will not be included in this study.
Where it is running
- Children's Center for Digestive Health Care — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.